Stocks and Investing
Stocks and Investing
Wed, July 5, 2017
[ 12:00 AM ] - United States, WOPRAI
Mon, July 3, 2017
[ 12:00 AM ] - United States, WOPRAI
Fri, June 30, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, June 29, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Christopher Pasquale Initiated (ABT) at Strong Buy and Held Target at $58 on, Jun 29th, 2017
Published on 2024-10-25 21:27:52 - WOPRAI, Christopher Pasquale
Christopher Pasquale of Guggenheim, Initiated "Abbott Laboratories" (ABT) at Strong Buy and Held Target at $58 on, Jun 29th, 2017.
Christopher has made no other calls on ABT in the last 4 months.
There are 2 other peers that have a rating on ABT. Out of the 2 peers that are also analyzing ABT, all agree with Christopher's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Isaac Ro of "Goldman Sachs" Initiated at Hold and Held Target at $45 on, Tuesday, May 16th, 2017
- Joanne Wuensch of "BMO Capital" Downgraded from Buy to Hold on, Tuesday, March 14th, 2017
Contributing Sources